FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS

• Published in: Retina (Philadelphia, Pa.) Vol. 40; no. 4; p. 695
• Main Authors: Sauer, Lydia, Vitale, Alexandra S, Andersen, Karl M, Hart, Barbara, Bernstein, Paul S
• Format: Journal Article
• Language: English
• Published: United States 01.04.2020
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Humans; Middle Aged; Ophthalmoscopy - methods; Optical Imaging - methods; Retinal Pigment Epithelium - pathology; Retinal Telangiectasis - diagnosis; Visual Acuity; Young Adult
• ISSN: 1539-2864
• DOI: 10.1097/IAE.0000000000002646

Macular telangiectasia Type 2 (MacTel) is an inherited retinal disease following an autosomal dominant pattern with late onset and reduced penetrance. Fluorescence lifetime imaging ophthalmoscopy (FLIO) enhances diagnosis by showing distinct changes in MacTel. This study investigates FLIO-associated changes in clinically unaffected family members. Eighty-one patients with MacTel (61 ± 12 years), 33 clinically healthy children under age 40 years of these MacTel patients (MacTel-C; 31 ± 6 years), 27 other family members (children over age 40 years, siblings, and parents) and 30 controls were investigated with the Heidelberg FLIO. All subjects underwent multimodal conventional imaging, including optical coherence tomography, blue-light reflectance, fluorescein angiography, and macular pigment imaging. All 81 patients with MacTel showed typical FLIO patterns. Of the 33 investigated MacTel-C with completely normal eye examinations and conventional imaging, 12 (36%) show FLIO patterns consistent with early MacTel. Prolonged FLIO lifetimes in the parafoveal area within the short spectral channel, especially temporally, are MacTel-specific. Fluorescence lifetime imaging ophthalmoscopy detects these lifetime patterns in over one-third of clinically unaffected MacTel-C. Although further studies will be necessary to determine the specificity of FLIO, it may help diagnose MacTel before conventional imaging modalities show changes or patients experience visual disturbances. Early detection may facilitate future gene discovery studies and interventional trials.